Biological Sciences Division
Published October 15, 2013 | Version v1
Patent Open

Therapeutics to inhibit MLL-menin interaction for treating leukemia

Creators

  • 1. University of Chicago

Contributors

Description

Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.

Files

US8557778.pdf

Files (664.2 kB)

Name Size Download all
md5:2977e820f3391cea3546b455702d5778
664.2 kB Preview Download

Additional details

Identifiers

Patent number
US 201213552126 A
Patent application number
US 8557778 B2
Other
oai:uchicago.tind.io:8276

Dates

Patent filed
2012-07-18

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine